Fertility-sparing surgery for patients with malignant ovarian germ cell tumors: 10 years of clinical experience from a tertiary referral center.
Mislav MikušNikolina BencoLuka MatakPavao PlaninićMario ĆorićHelena LovrićVelena RadoševićTomislav PuževskiMirna BajtGoran VujićPublished in: Archives of gynecology and obstetrics (2020)
This study suggests that FSS is a safe treatment option for MOGCT, regardless of tumor stage and histological type.